Dr. Rayne Helen Rouce, MD

  • Houston, TX
  • Pediatrician
NPI1770774960
Part D claims, 2018
22
Publications
51
Clinical trials
3
Hospital affiliations
2
Industry payments
$48,335
Practice address
6621 Fannin Street, Houston, TX 77030
Practice phone
Call (832) 824-1000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Texas Children's Hospital

Hospital · Houston, Texas

Find Dr. Rouce's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Rayne Helen Rouce is a pediatrician in Houston, Texas

Dr. Rouce practices at Texas Children's Hospital in Houston, Texas, part of Texas Children's Hospital.

Dr. Rouce's NPI, 1770774960, was assigned on August 5, 2007. Dr. Rouce graduated from UTMB Health in 2007. Dr. Rouce holds Texas license BP1-0029099.

NPI and contact details
NPI enumeration date
August 5, 2007
NPI status
Active
Practice phone
(832) 824-1000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Medical school graduation
2007

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data

Dr. Rayne Helen Rouce practices at Texas Children's Hospital in Houston, Texas

Dr. Rouce's primary practice is Texas Children's Hospital, at 6621 Fannin Street, Houston, TX 77030 in Harris County. The practice phone is (832) 824-1000.

Source: Dmand AI Affiliation Data

Dr. Rayne Helen Rouce is affiliated with 2 sites of care and 1 medical group

Dr. Rouce's primary practice is Texas Children's Hospital in Houston, Texas, part of Texas Children's Hospital. Dr. Rouce is also affiliated with John Sealy Hospital. The medical group on file is Texas Children's Hospital.

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Rayne Helen Rouce's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rouce practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Texas Children's HospitalAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Rouce practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Texas Children's Hospital and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Rayne Helen Rouce is one of 4,833 pediatricians in Texas

Pediatrics is Dr. Rouce's primary specialty in the NPI Registry, under taxonomy code 208000000X. Dr. Rouce is board certified in pediatric hematology-oncology by the American Board of Pediatrics. Dr. Rouce is licensed in Texas.

Specialties and state licenses

  • Pediatrics, TexasPrimaryLicense BP1-0029099 · 2010 to 2026 · taxonomy 208000000X

Pediatricians near Dr. Rouce

Counts of pediatricians with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Rayne Helen Rouce's patients have a median age of 8

Across all payers, Dmand AI patient panel data puts Dr. Rouce's median patient age at 8, with 30% women.

Dr. Rouce's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 8

Patient panel by sex, all payers

  • Women30%
  • Men70%

Source: Dmand AI Patient Panel Data

Dr. Rayne Helen Rouce wrote 22 Medicare Part D claims in 2018

In 2018, Dr. Rouce wrote 22 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $8,109 in total drug cost.

Part D claims, 201822
Drugs named by CMS1
Total drug cost$8,109

Dr. Rouce's most prescribed drugs by claims, 2018

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

See all prescribing by Dr. Rouce

Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026

For MedTech and pharma teams

Find pediatricians like Dr. Rouce by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Rayne Helen Rouce has 51 publications on record

Dmand AI links 51 papers to Dr. Rouce, published from 2011 to 2025. 2024 was the busiest year, with 6. The most frequent topics are Immunotherapy, Adoptive, T-Lymphocytes and Receptors, Chimeric Antigen. Dr. Rouce has published most often in Blood. Dr. Rouce's most frequent co-authors are Helen E. Heslop, MD, Malcolm Brenner, MD and Premal Dilip Lulla, MD.

Papers51
Years published2011 to 2025

Dr. Rouce's papers by year, 2016 to 2025

Topics Dr. Rouce writes about most

  • Immunotherapy, Adoptive
  • T-Lymphocytes
  • Receptors, Chimeric Antigen
  • Receptors, Antigen, T-Cell
  • Antigens, CD19
  • Cell- and Tissue-Based Therapy
  • Hematopoietic Stem Cell Transplantation
  • Health Services Accessibility

Dr. Rouce's most frequent co-authors

Recent publications by Dr. Rouce

See all 51 publications and co-authors

See who Dr. Rouce researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Rouce works with, so you can find a warm path to the right pediatricians.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Rayne Helen Rouce has worked on 3 clinical trials

Dmand AI links Dr. Rouce to 3 clinical trials, 3 of them phase 1 studies. 2 are still active or recruiting. Conditions studied include Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma and Leukemia, Lymphoid. Baylor College of Medicine sponsors the most, 3.

Conditions in Dr. Rouce's trials

  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
  • Leukemia, Lymphoid

Investigators on the most trials with Dr. Rouce

Recent clinical trials with Dr. Rouce

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Rayne Helen Rouce received $48,335 in industry payments from 2016 to 2025

CMS Open Payments shows 37 general payments to Dr. Rouce from 5 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 80% of the total. Novartis Pharmaceuticals Corporation paid the most, $24,652. It also lists 3 research payments totaling $1,547 from 2022 to 2024.

General payments to Dr. Rouce by program year, 2016 to 2025

General payments to Dr. Rouce by kind, 2016 to 2025

$48.3Kin total
  • Consulting fees$38,58580%
  • Travel and lodging$4,3709%
  • Honoraria$3,7508%
  • Food and beverage$1,5753%
  • Gifts$550%

Companies that paid Dr. Rouce the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Rouce

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Rayne Helen Rouce graduated from UTMB Health

Dr. Rouce graduated from UTMB Health in 2007.

  1. Medical schoolUTMB Health
  2. Board certified in pediatric hematology-oncologyAmerican Board of Pediatrics
  3. Board certified in pediatricsAmerican Board of Pediatrics

Source: Dmand AI Professional Profile Data

Dr. Rayne Helen Rouce accepts plans from 2 insurance carriers

Dr. Rouce is in network with 2 carriers, including Aetna and Blue Cross Blue Shield of Michigan. POS plans come from the most carriers, 2. Check the plan with the practice before a visit.

  • Aetna
  • Blue Cross Blue Shield of Michigan

Plan types Dr. Rouce accepts, by number of carriers

  1. POS2
  2. PPO2
  3. EPO1
  4. HMO1
  5. Medicare1

Source: Dmand AI Insurance Network Data

Sources for Dr. Rayne Helen Rouce's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Rayne Helen Rouce

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Rayne Helen Rouce's NPI number?

Dr. Rayne Helen Rouce's NPI number is 1770774960. It was assigned on August 5, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Rayne Helen Rouce?

Dr. Rayne Helen Rouce is a pediatrician in Houston, Texas. The primary specialty in the NPI Registry is Pediatrics Physician (taxonomy code 208000000X).

Where does Dr. Rayne Helen Rouce practice?

Dr. Rouce practices at 6621 Fannin Street, Houston, TX 77030. Dr. Rouce's primary practice is Texas Children's Hospital in Houston, Texas, part of Texas Children's Hospital.

What is Dr. Rayne Helen Rouce's office phone number?

The practice phone on file for Dr. Rouce is (832) 824-1000.

What is Dr. Rayne Helen Rouce's medical license number?

Dr. Rouce holds Texas license BP1-0029099.

Which hospitals is Dr. Rayne Helen Rouce affiliated with?

Dr. Rouce practices at Texas Children's Hospital in Houston, Texas. Dr. Rouce is also affiliated with John Sealy Hospital.

What medical group is Dr. Rayne Helen Rouce part of?

Dr. Rouce is linked to Texas Children's Hospital.

Is Dr. Rayne Helen Rouce board certified?

Yes. Dr. Rouce is board certified in pediatric hematology-oncology by the American Board of Pediatrics.

Where did Dr. Rayne Helen Rouce go to medical school?

Dr. Rouce graduated from UTMB Health in 2007.

What drugs does Dr. Rayne Helen Rouce prescribe most?

In 2018 Medicare Part D data, Dr. Rouce's most prescribed drugs by claims were Enoxaparin Sodium.

Show 5 more questionsShow fewer questions

Has Dr. Rayne Helen Rouce received payments from drug or device companies?

CMS Open Payments shows $48,335 in general payments to Dr. Rouce from 5 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.

How long has Dr. Rayne Helen Rouce been practicing?

Dr. Rouce graduated from medical school in 2007, 19 years ago.

Does Dr. Rayne Helen Rouce do research?

Dmand AI links 51 publications to Dr. Rouce, published from 2011 to 2025. Dr. Rouce has worked on 3 clinical trials.

Who does Dr. Rayne Helen Rouce publish with?

Dr. Rouce's most frequent co-authors are Helen E. Heslop, MD (12 shared papers), Malcolm Brenner, MD (11 shared papers) and Premal Dilip Lulla, MD (6 shared papers).

What insurance does Dr. Rayne Helen Rouce accept?

Dr. Rouce is in network with 2 carriers, including Aetna and Blue Cross Blue Shield of Michigan. POS plans come from the most carriers, 2. Check the plan with the practice before a visit.

Selling to pediatrics practices?

See pediatricians in Texas by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)